Akebia Therapeutics, Inc. (AKBA)
$0.80-1.23%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $215M
- Beta
- 0.23
- P/E (TTM)
- -8.13
- Short % float
- 8.58%
- Days to cover
- 3.5
- SI change
- +9.6%
- 1W
- -6.98%
- 1M
- -15.79%
- vs SPY 1W
- -8.14%
- vs SPY 1M
- -18.78%
Industry peers
FMP comparable companies · ranked by market cap
- KALVKalVista Pharmaceuticals, Inc.$1.4B$27.00
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- RIGLBUYRigel Pharmaceuticals, Inc.$908MBULLQ 9$49.08+0.74%
- CRVSSELLCorvus Pharmaceuticals, Inc.$885MCRISISQ 13$10.52+3.04%
- FDMTSELL4D Molecular Therapeutics, Inc.$697MCRISISQ 4$13.33+4.96%
- OLMASELLOlema Pharmaceuticals, Inc.$683MCRISISQ -1$7.82+0.00%
- ZVRASELLZevra Therapeutics, Inc.$673MRECOVERYQ -7$11.39+3.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
